Submitted by Anonymous (not verified) on 7 October 2026 - 15:30
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 38, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 38, Status: Authorised